UBS O'Connor’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $898K | Sell |
79,460
-90,232
| -53% | -$1.02M | 0.05% | 216 |
|
|
2025
Q1 | $1.96M | Sell |
169,692
-3,001
| -2% | -$34.6K | 0.06% | 117 |
|
|
2024
Q4 | $1.46M | Buy |
172,693
+37,141
| +27% | +$315K | 0.04% | 189 |
|
|
2024
Q3 | $1.57M | Buy |
135,552
+12,592
| +10% | +$146K | 0.04% | 207 |
|
|
2024
Q2 | $1.45M | Buy |
122,960
+40,960
| +50% | +$483K | 0.04% | 237 |
|
|
2024
Q1 | $973K | Buy |
+82,000
| New | +$973K | 0.03% | 274 |
|